Melina Rojas Criollo

Ms. Melina Rojas Criollo

Biochemistry and biotechnology, Universitat Rovira i Virgili, Tarragona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
LTLaia Gutierrez Tordera
Laia Gutierrez Tordera
AFAlexandre Folch
Alexandre Folch
MCMelina Rojas Criollo
Melina Rojas Criollo
JCJose L. Cantero
Jose L. Cantero
MAMercedes Atienza
Mercedes Atienza
MBMonica Bullo
Monica Bullo
New dietary approaches for the prevention of cognitive impairment are being investigated. However, evidence from dietary interventions is mainly from food and nutrient supplement interventions, with inconsistent results and high heterogeneity between trials. We conducted a comprehensive systematic search of randomized controlled trials (RCTs) published in MEDLINE-PubMed, from January 2018 to July 2021, investigating the impact of dietary counseling, as well as food-based and dietary supplement interventions on cognitive function in adults with or without cognitive impairment. Based on the search strategy, 197 eligible publications were used for data abstraction. Finally, 61 articles were included in the analysis. There was reasonable evidence that dietary patterns, as well as food and dietary supplements improved cognitive domains or measures of brain integrity. The Mediterranean diet showed promising results, whereas the role of the DASH diet was not clear. Healthy food consumption improved cognitive function, although the quality of these studies was relatively low. The role of dietary supplements was mixed, with strong evidence of the benefits of polyphenols and combinations of nutrients, but with low evidence for PUFAs, vitamin D, specific protein, amino acids, and other types of supplements. Further well-designed RCTs are needed to guide the development of dietary approaches for the prevention of cognitive impairment.

26 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMelina Rojas Criollo
Melina Rojas Criollo
NNNil Novau-Ferré
Nil Novau-Ferré
LTLaia Gutierrez Tordera
Laia Gutierrez Tordera
MEMiren Ettcheto
Miren Ettcheto
JFJaume Folch
Jaume Folch
MBMonica Bullo
Monica Bullo
Insulin resistance (IR)-related miRNAs have been associated with the development and progression of Alzheimer’s disease (AD). The dietary modulation of these miRNAs could become a potential strategy to manage AD. The aim of this study was to evaluate the effect of a high-fat diet (HFD), which aggravates AD-related pathogenic processes, on serum, cortex and hippocampus IR-related miRNA expression. C57BL/6J WT and APPSwe/PS1dE9 mice were fed either an HFD or a conventional diet till 6 months of age. The mice fed with the HFD showed a significant increase in body weight and worsening glucose and insulin metabolism. miR-19a-3p was found to be up-regulated in the cortex, hippocampus and serum of APP/PS1 mice and in the serum and hippocampus of WT mice fed with the HFD. miR-34a-5p and miR-146a-5p were up-regulated in the serum of both groups of mice after consuming the HFD. Serum miR-29c-3p was overexpressed after consuming the HFD, along with hippocampal miR-338-3p and miR-125b-5p, only in WT mice. The HFD modulated the expression of peripheral and brain miRNAs related to glucose and insulin metabolism, suggesting the potential role of these miRNAs not only as therapeutic targets of AD but also as peripheral biomarkers for monitoring AD.

1 January 2024 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
JMJavier Mateu-Fabregat
Javier Mateu-Fabregat
Christopher PapandreouChristopher Papandreou
Christopher Papandreou
LTLaia Gutierrez Tordera
Laia Gutierrez Tordera
MCMelina Rojas Criollo
Melina Rojas Criollo
NNNil Novau-Ferré
Nil Novau-Ferré
MBMonica Bullo
Monica Bullo
Mateu-Fabregat J, et al. World J Mens Health. 2024 Apr;42:e53. https://doi.org/10.5534/wjmh.230328

3 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
NNNil Novau-Ferré
Nil Novau-Ferré
MCMelina Rojas Criollo
Melina Rojas Criollo
LTLaia Gutierrez Tordera
Laia Gutierrez Tordera
PAPierre Arcelin
Pierre Arcelin
JFJaume Folch
Jaume Folch
MBMonica Bullo
Monica Bullo
Telomere length (TL) is a well-known marker of age-related diseases. Oxidative stress and inflammation increase the rate of telomere shortening, triggering cellular senescence. Although lipoproteins could have anti-inflammatory and proinflammatory functional properties, the relationship between lipoprotein particles with TL and telomerase activity-related genes has not been investigated much. In this study, we assessed the associations of lipoprotein subfractions with telomere length, TERT, and WRAP53 expression in a total of 54 pre-diabetic subjects from the EPIRDEM study. We regressed TL, TERT, and WRAP53 on 12 lipoprotein subclasses, employing a Gaussian linear regression method with Lasso penalty to determine a lipoprotein profile associated with telomere-related parameters. The covariates included age, sex, body mass index (BMI), dyslipidemia, statin consumption, and physical activity leisure time. We identified a lipoprotein profile composed of four lipoprotein subfractions associated with TL (Pearson r = 0.347, p-value = 0.010), two lipoprotein subfractions associated with TERT expression (Pearson r = 0.316, p-value = 0.020), and five lipoprotein subfractions associated with WRAP53 expression (Pearson r = 0.379, p-value =0.005). After adjusting for known confounding factors, most lipoprotein profiles maintained the association with TL, TERT, and WRAP53. Overall, medium and small-sized HDL particles were associated with shorter telomeres and lower expression of TERT and WRAP53. Large HDL particles were associated with longer telomere and lower expression of WRAP53, but not with TERT. Our results suggest that the lipoprotein profiles are associated with telomere length, TERT, and WRAP53 expression and should be considered when assessing the risk of chronic diseases.